The firm filed for Chapter 11 protection on Thursday and is seeking to sell its assets after facing turmoil in recent years.

NEW YORK – The World Health Organization announced on Friday that its Medicines Patent Pool has sublicensed technology for rapid diagnostic testing to Nigeria’s Codix Bio.

The money will support the development of the firm's PidPort system for storage, viewing, sharing, and analysis of digital images of pathology slides.

April's clearances included respiratory disease assays, a Gram-negative infection test, and assays to aid the diagnosis and monitoring of thyroid disease.

The company has received a commitment of up to $12.5 million in a multi-draw DIP financing facility to provide funding during the proceeding.

NEW YORK — Exagen, a developer of autoimmune testing technologies, said on Thursday it expects to raise around $17.6 million through a public offering of its common stock.

The firm has been engaging with payors and insurance plan administrators following the release of results from its study on the use of the firm's PreTRM Test.

The firm reported that its total revenues jumped 9 percent in Q2, but it lowered the low end of its EPS guidance to account for the uncertainty of tariffs and other trade barriers.

The Diagnostics and Spatial Biology segment's revenues were up 2 percent compared to the prior-year quarter, while Protein Sciences revenues rose 6 percent.